http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0669824-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a722744e77c81c5f5cf415087e2ee92b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
filingDate 1993-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d709dac36a86c032a2cc7834c81b9f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9b73ad6f46c3b18722ea6c064e6ef77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b9affb5a4ea96b9b0d57557ad1b91d
publicationDate 1995-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0669824-A4
titleOfInvention Use of cardiotonic agents and inhibitors of nitrogen synthesis to limit pathological circulatory disorders.
abstract The present invention involves a method for prophylaxis or treatment of an animal for systemic hypotension induced by endotoxin and/or a biological response modifier such as the cytokines, IFN, TNF, IL-1 or IL-2 and the like. The method involves administering, preferably intravascularly, a therapeutically effective amount of dobutamine and an inhibitor of nitric oxide formation from arginine.
priorityDate 1992-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227563644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226684491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18645875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18645876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737

Total number of triples: 63.